Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection

Hormones and Behavior

Volumn 57, Issue 1, 2010, Pages 2-11

  Cosimo Melcangi, Roberto ^a   Garcia Segura, Luis Miguel ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Alzheimer's disease; Huntington's disease; Multiple sclerosis; Parkinson's disease; Peripheral neuropathy; Psychiatric disorders; Sex difference; Sex steroids; Stroke; Traumatic brain injury

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; AMYLOID BETA PROTEIN; DOPAMINE; ESTRADIOL; ESTROGEN; GAMMA INTERFERON; GLUTATHIONE; HUNTINGTIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYL CPG BINDING PROTEIN 2; NEUROHORMONE; NEUROSTEROID; PROGESTERONE; REELIN; SEX HORMONE; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALZHEIMER DISEASE; ANXIETY DISORDER; AUTISM; CAUSAL ATTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG MECHANISM; DRUG SCREENING; EATING DISORDER; EPILEPSY; HORMONE ACTION; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MENTAL HEALTH; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; SEX DIFFERENCE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; SEX CHARACTERISTICS; STEROIDS;

EID: 73049114855     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.06.001     Document Type: Review

References (206)

1. Aaberg M.L., Burch D.M., Hud Z.R., and Zacharias M.P. Gender differences in the onset of diabetic neuropathy. J. Diabetes Complicat. 22 (2008) 83-87
2. Afifi M. Gender differences in mental health. Singapore Med. J. 48 (2007) 385-391
3. Albers J.W., Brown M.B., Sima A.A., and Greene D.A. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 46 (1996) 85-91
4. Ammendola A., Gemini D., Iannaccone S., Argenzio F., Ciccone G., Ammendola E., Serio L., Ugolini G., and Bravaccio F. Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol Alcohol. 35 (2000) 368-371
5. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R., Dartigues J.F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., and Hofman A. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group. Neurology 53 (1999) 1992-1997
6. Andreasen N.C., Ehrhardt J.C., Swayze II V.W., Alliger R.J., Yuh W.T., Cohen G., and Ziebell S. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry 47 (1990) 35-44
7. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze II V., O Leary D.S., Ehrhardt J.C., and Yuh W.T. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272 (1994) 1763-1769
8. Arnold A.P., and Burgoyne P.S. Are XX and XY brain cells intrinsically different?. Trends Endocrinol. Metab. 15 (2004) 6-11
9. Arnold A.P., and Gorski R.A. Gonadal steroid induction of structural sex differences in the central nervous system. Annu. Rev. Neurosci. 7 (1984) 413-442
10. Arnold A.P., Xu J., Grisham W., Chen X., Kim Y.H., and Itoh Y. Minireview: sex chromosomes and brain sexual differentiation. Endocrinology 145 (2004) 1057-1062
11. Azcoitia I., Fernandez-Galaz C., Sierra A., and Garcia-Segura L.M. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J. Neurocytol. 28 (1999) 699-710
12. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., and Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 47 (2001) 318-329
13. Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum. Psychopharmacol. 23 (2008) 201-209
14. Basit A., Hydrie M.Z., Hakeem R., Ahmedani M.Y., and Masood Q. Frequency of chronic complications of type II diabetes. J. Coll. Physicians Surg. Pak. 14 (2004) 79-83
15. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998) 963-987
16. Bauman M.L., and Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23 (2005) 183-187
17. Bayir H., Marion D.W., Puccio A.M., Wisniewski S.R., Janesko K.L., Clark R.S., and Kochanek P.M. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J. Neurotrauma 21 (2004) 1-8
18. Bebo Jr. B.F., Adlard K., Schuster J.C., Unsicker L., Vandenbark A.A., and Offner H. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J. Neurosci. Res. 55 (1999) 432-440
19. Beinhoff U., Tumani H., Brettschneider J., Bittner D., and Riepe M.W. Gender-specificities in Alzheimer's disease and mild cognitive impairment. J. Neurol. 255 (2008) 117-122
20. Benito-Leon J., Bermejo-Pareja F., Rodriguez J., Molina J.A., Gabriel R., and Morales J.M. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov. Disord. 18 (2003) 267-274
21. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T.A., Langui D., Duyckaerts C., Tremp G., and Pradier L. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 184 (2003) 247-263
22. Bloch Y., Ratzoni G., Sobol D., Mendlovic S., Gal G., and Levkovitz Y. Gender differences in electroconvulsive therapy: a retrospective chart review. J. Affect. Disord. 84 (2005) 99-102
23. Bode F.J., Stephan M., Suhling H., Pabst R., Straub R.H., Raber K.A., Bonin M., Nguyen H.P., Riess O., Bauer A., Sjoberg C., Petersen A., and von Horsten S. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 17 (2008) 2595-2609
24. Booya F., Bandarian F., Larijani B., Pajouhi M., Nooraei M., and Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 5 (2005) 24
25. Bryant N.L., Buchanan R.W., Vladar K., Breier A., and Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am. J. Psychiatry 156 (1999) 603-609
26. Cahill L. Why sex matters for neuroscience. Nat. Rev., Neurosci. 7 (2006) 477-484
27. Callahan M.J., Lipinski W.J., Bian F., Durham R.A., Pack A., and Walker L.C. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158 (2001) 1173-1177
28. Cantuti-Castelvetri I., Keller-McGandy C., Bouzou B., Asteris G., Clark T.W., Frosch M.P., and Standaert D.G. Effects of gender on nigral gene expression and Parkinson disease. Neurobiol. Dis. 26 (2007) 606-614
29. Canuso C.M., Goldstein J.M., Wojcik J., Dawson R., Brandman D., Klibanski A., Schildkraut J.J., and Green A.I. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 111 (2002) 11-20
30. Caruso D., Scurati S., Roglio I., Nobbio L., Schenone A., and Melcangi R.C. Neuroactive steroid levels in a transgenic rat model of CMT1A neuropathy. J. Mol. Neurosci. 34 (2008) 249-253
31. Celius E.G., Harbo H.F., Egeland T., Vartdal F., Vandvik B., and Spurkiand A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J. Neurol. Sci. 178 (2000) 132-135
32. Cerghet M., Skoff R.P., Bessert D., Zhang Z., Mullins C., and Ghandour M.S. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 26 (2006) 1439-1447
33. Cheng J., Alkayed N.J., and Hurn P.D. Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J. Cereb. Blood Flow Metab. 27 (2007) 1553-1562
34. Clinton L.K., Billings L.M., Green K.N., Caccamo A., Ngo J., Oddo S., McGaugh J.L., and LaFerla F.M. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol. Dis. 28 (2007) 76-82
35. Confavreux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003) 770-782
36. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., and Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002) 1-6
37. Czlonkowska A., Ciesielska A., Gromadzka G., and Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29 (2006) 243-256
38. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., and Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374 (1995) 719-723
39. Datla K.P., Murray H.E., Pillai A.V., Gillies G.E., and Dexter D.T. Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. NeuroReport 14 (2003) 47-50
40. Davis D.P., Douglas D.J., Smith W., Sise M.J., Vilke G.M., Holbrook T.L., Kennedy F., Eastman A.B., Velky T., and Hoyt D.B. Traumatic brain injury outcomes in pre- and post- menopausal females versus age-matched males. J. Neurotrauma 23 (2006) 140-148
41. de Lau L.M., Giesbergen P.C., de Rijk M.C., Hofman A., Koudstaal P.J., and Breteler M.M. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63 (2004) 1240-1244
42. de Olmos S., Bueno A., Bender C., Lorenzo A., and de Olmos J. Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat. Brain Struct. Funct. 213 (2008) 229-238
43. Devroey D., Van Casteren V., and Buntinx F. Registration of stroke through the Belgian sentinel network and factors influencing stroke mortality. Cerebrovasc. Dis. 16 (2003) 272-279
44. di Michele F., Lekieffre D., Pasini A., Bernardi G., Benavides J., and Romeo E. Increased neurosteroids synthesis after brain and spinal cord injury in rats. Neurosci. Lett. 284 (2000) 65-68
45. Dina O.A., Gear R.W., Messing R.O., and Levine J.D. Severity of alcohol-induced painful peripheral neuropathy in female rats: role of estrogen and protein kinase (A and Cepsilon). Neuroscience 145 (2007) 350-356
46. Dluzen D., and Horstink M. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies. Endocrine 21 (2003) 67-75
47. Dooley M.A., and Hogan S.L. Environmental epidemiology and risk factors for autoimmune disease. Curr. Opin. Rheumatol. 15 (2003) 99-103
48. Dorner J.L., Miller B.R., Barton S.J., Brock T.J., and Rebec G.V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav. Brain Res. 178 (2007) 90-97
49. Doulazmi M., Frederic F., Lemaigre-Dubreuil Y., Hadj-Sahraoui N., Delhaye-Bouchaud N., and Mariani J. Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora(+)/Rora(sg)) is gender-related. J. Comp. Neurol. 411 (1999) 267-273
50. Elias A.N., and Hofflich H. Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications. Am. J. Med. 121 (2008) 98-104
51. England J.D., and Asbury A.K. Peripheral neuropathy. Lancet 363 (2004) 2151-2161
52. Eriksson M., Norrving B., Terent A., and Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc. Dis. 25 (2008) 423-429
53. Farace E., and Alves W.M. Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome. J. Neurosurg. 93 (2000) 539-545
54. Fernandez H.H., Lapane K.L., Ott B.R., and Friedman J.H. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov. Disord. 15 (2000) 490-496
55. Fex Svenningsen A., and Kanje M. Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner. J. Neurosci. Res. 57 (1999) 124-130
56. Fillmore P.D., Blankenhorn E.P., Zachary J.F., and Teuscher C. Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am. J. Pathol. 164 (2004) 167-175
57. Fombonne E. The epidemiology of autism: a review. Psychol. Med. 29 (1999) 769-786
58. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 33 (2003) 365-382
59. Foot M., and Koszycki D. Gender differences in anxiety-related traits in patients with panic disorder. Depress. Anxiety 20 (2004) 123-130
60. Foroud T., Gray J., Ivashina J., and Conneally P.M. Differences in duration of Huntington's disease based on age at onset. J. Neurol. Neurosurg. Psychiatry 66 (1999) 52-56
61. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997) 132-138
62. Galanopoulou A.S., Alm E.M., and Veliskova J. Estradiol reduces seizure-induced hippocampal injury in ovariectomized female but not in male rats. Neurosci. Lett. 342 (2003) 201-205
63. Galea L.A. Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res. Rev. 57 (2008) 332-341
64. Galimberti D., Scalabrini D., Fenoglio C., De Riz M., Comi C., Venturelli E., Cortini F., Piola M., Leone M., Dianzani U., D'Alfonso S., Monaco F., Bresolin N., and Scarpini E. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. J. Neurol. Sci. 267 (2008) 86-90
65. Garcia-Segura L.M., Lorenz B., and DonCarlos L.L. The role of glia in the hypothalamus: implications for gonadal steroid feedback and reproductive neuroendocrine output. Reproduction 135 (2008) 419-429
66. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., and Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol. 71 (2003) 31-41
67. Gemignani F., Brindani F., Negrotti A., Vitetta F., Alfieri S., and Marbini A. Restless legs syndrome and polyneuropathy. Mov. Disord. 21 (2006) 1254-1257
68. Gillies G.E., Murray H.E., Dexter D., and McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol. Biochem. Behav. 78 (2004) 513-522
69. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 28 (2007) 1-6
70. Goldstein J.M. Sex, hormones and affective arousal circuitry dysfunction in schizophrenia. Horm. Behav. 50 (2006) 612-622
71. Goldstein J.M., and Link B.G. Gender and the expression of schizophrenia. J. Psychiatr. Res. 22 (1988) 141-155
72. Goldstein J.M., Seidman L.J., Goodman J.M., Koren D., Lee H., Weintraub S., and Tsuang M.T. Are there sex differences in neuropsychological functions among patients with schizophrenia?. Am. J. Psychiatry 155 (1998) 1358-1364
73. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch. Gen. Psychiatry 59 (2002) 154-164
74. Goldstein J.M., Seidman L.J., Makris N., Ahern T., O'Brien L.M., Caviness Jr. V.S., Kennedy D.N., Faraone S.V., and Tsuang M.T. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol. Psychiatry 61 (2007) 935-945
75. Groswasser Z., Cohen M., and Keren O. Female TBI patients recover better than males. Brain Inj. 12 (1998) 805-808
76. Group, H. s. D. C. R. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
77. Gue M., Bravard A., Meunier J., Veyrier R., Gaillet S., Recasens M., and Maurice T. Sex differences in learning deficits induced by prenatal stress in juvenile rats. Behav. Brain Res. 150 (2004) 149-157
78. Guillem F., Mendrek A., Lavoie M.E., Pampoulova T., and Stip E. Sex differences in memory processing in schizophrenia: an event-related potential (ERP) study. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2008) 1-10
79. Gupta S., Aggarwal S., Rashanravan B., and Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 85 (1998) 106-109
80. Gur R.E., Kohler C., Turetsky B.I., Siegel S.J., Kanes S.J., Bilker W.B., Brennan A.R., and Gur R.C. A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol. Psychiatry 55 (2004) 512-517
81. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J., Leenders K.L., Eshuis S., Booij J., Dluzen D.E., and Horstink M.W. Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007) 819-824
82. Hadj-Sahraoui N., Frederic F., Delhaye-Bouchaud N., and Mariani J. Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. J. Neurogenet. 11 (1996) 45-58
83. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl. 2 (2003) 17-54
84. Halbreich U., and Kahn L.S. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28 Suppl. 2 (2003) 1-16
85. Hankin B.L., and Abramson L.Y. Development of gender differences in depression: description and possible explanations. Ann. Med. 31 (1999) 372-379
86. Hawkins S.A., and McDonnell G.V. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J. Neurol. Neurosurg. Psychiatry 67 (1999) 148-152
87. Hirata-Fukae C., Li H.F., Hoe H.S., Gray A.J., Minami S.S., Hamada K., Niikura T., Hua F., Tsukagoshi-Nagai H., Horikoshi-Sakuraba Y., Mughal M., Rebeck G.W., LaFerla F.M., Mattson M.P., Iwata N., Saido T.C., Klein W.L., Duff K.E., Aisen P.S., and Matsuoka Y. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 1216 (2008) 92-103
88. Holroyd-Leduc J.M., Kapral M.K., Austin P.C., and Tu J.V. Sex differences and similarities in the management and outcome of stroke patients. Stroke 31 (2000) 1833-1837
89. Homann C.N., Quehenberger F., Petrovic K., Hartung H.P., Ruzicka E., Homann B., Suppan K., Wenzel K., Ivanic G., and Ott E. Influence of age, gender, education and dexterity on upper limb motor performance in Parkinsonian patients and healthy controls. J. Neural Transm. 110 (2003) 885-897
90. Hyman B.T. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol. Aging 18 (1997) S27-32
91. Jacobson D.L., Gange S.J., Rose N.R., and Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84 (1997) 223-243
92. Joseph E.K., and Levine J.D. Sexual dimorphism in the contribution of protein kinase C isoforms to nociception in the streptozotocin diabetic rat. Neuroscience 120 (2003) 907-913
93. Kantarci O.H., Hebrink D.D., Achenbach S.J., Atkinson E.J., de Andrade M., McMurray C.T., and Weinshenker B.G. CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS. J. Neuroimmunol. 146 (2004) 162-170
94. Kapral M.K., Fang J., Hill M.D., Silver F., Richards J., Jaigobin C., and Cheung A.M. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 36 (2005) 809-814
95. Katz A., Mirzatoni A., Zhen Y., and Schlinger B.A. Sex differences in cell proliferation and glucocorticoid responsiveness in the zebra finch brain. Eur. J. Neurosci. 28 (2008) 99-106
96. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol. Behav. 94 (2008) 121-135
97. Kimura K., Minematsu K., Kazui S., and Yamaguchi T. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc. Dis. 19 (2005) 171-178
98. Kiziltan M.E., Gunduz A., Kiziltan G., Akalin M.A., and Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J. Neurol. Sci. 258 (2007) 75-79
99. Kovacic U., Sketelj J., and Bajrovic F.F. Sex-related difference in collateral sprouting of nociceptive axons after peripheral nerve injury in the rat. Exp. Neurol. 184 (2003) 479-488
100. Kovacic U., Zele T., Osredkar J., Sketelj J., and Bajrovic F.F. Sex-related differences in the regeneration of sensory axons and recovery of nociception after peripheral nerve crush in the rat. Exp. Neurol. 189 (2004) 94-104
101. Kraszpulski M., Soininen H., Helisalmi S., and Alafuzoff I. The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer's disease. Acta Neurol. Scand. 103 (2001) 88-92
102. Kraus J.F., Peek-Asa C., and McArthur D. The independent effect of gender on outcomes following traumatic brain injury: a preliminary investigation. Neurosurg. Focus 8 (2000) e5
103. Kurian J.R., Forbes-Lorman R.M., and Auger A.P. Sex difference in mecp2 expression during a critical period of rat brain development. Epigenetics 2 (2007) 173-178
104. Lang J.T., and McCullough L.D. Pathways to ischemic neuronal cell death: are sex differences relevant?. J. Transl. Med. 6 (2008) 33
105. Langlois J.A., Marr A., Mitchko J., and Johnson R.L. Tracking the silent epidemic and educating the public: CDC's traumatic brain injury-associated activities under the TBI Act of 1996 and the Children's Health Act of 2000. J. Head Trauma Rehabil. 20 (2005) 196-204
106. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., and McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293 (2001) 1487-1491
107. Lin Y., Ter Horst G.J., Wichmann R., Bakker P., Liu A., Li X., and Westenbroek C. Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb. Cortex. 19 (2009) 1978-1989
108. Liu H., Harrell L.E., Shenvi S., Hagen T., and Liu R.M. Gender differences in glutathione metabolism in Alzheimer's disease. J. Neurosci. Res. 79 (2005) 861-867
109. Liu H.H., Payne H.R., Wang B., and Brady S.T. Gender differences in response of hippocampus to chronic glucocorticoid stress: role of glutamate receptors. J. Neurosci. Res. 83 (2006) 775-786
110. Liu M., Hurn P.D., Roselli C.E., and Alkayed N.J. Role of P450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab. 27 (2007) 135-141
111. Lloret A., Badia M.C., Mora N.J., Ortega A., Pallardo F.V., Alonso M.D., Atamna H., and Vina J. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease. Free Radic. Biol. Med. 44 (2008) 2019-2025
112. Lopez O.L., Smith G., Becker J.T., Meltzer C.C., and DeKosky S.T. The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. J. Neuropsychiatry Clin. Neurosci. 13 (2001) 50-55
113. Lord C., Cook E.H., Leventhal B.L., and Amaral D.G. Autism spectrum disorders. Neuron 28 (2000) 355-363
114. MacLusky N.J., and Naftolin F. Sexual differentiation of the central nervous system. Science 211 (1981) 1294-1302
115. Magnaghi V., Veiga S., Ballabio M., Gonzalez L.C., Garcia-Segura L.M., and Melcangi R.C. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells. J. Peripher. Nerv. Syst. 11 (2006) 111-118
116. Mann K., Ackermann K., Croissant B., Mundle G., Nakovics H., and Diehl A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?. Alcohol Clin. Exp. Res. 29 (2005) 896-901
117. Marceglia S., Mrakic-Sposta S., Foffani G., Cogiamanian F., Caputo E., Egidi M., Barbieri S., and Priori A. Gender-related differences in the human subthalamic area: a local field potential study. Eur. J. Neurosci. 24 (2006) 3213-3222
118. Marcus S.M., Kerber K.B., Rush A.J., Wisniewski S.R., Nierenberg A., Balasubramani G.K., Ritz L., Kornstein S., Young E.A., and Trivedi M.H. Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr. Psychiatry 49 (2008) 238-246
119. Marsden C.D., and Olanow C.W. The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality. Ann. Neurol. 44 (1998) S189-196
120. Martinelli P., Contin M., Scaglione C., Riva R., Albani F., and Baruzzi A. Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?. Neurol. Sci. 24 (2003) 192-193
121. Matarese G., Sanna V., Di Giacomo A., Lord G.M., Howard J.K., Bloom S.R., Lechler R.I., Fontana S., and Zappacosta S. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 31 (2001) 1324-1332
122. Matejuk A., Hopke C., Vandenbark A.A., Hurn P.D., and Offner H. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol. 174 (2005) 2387-2395
123. McArthur S., Murray H.E., Dhankot A., Dexter D.T., and Gillies G.E. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. J. Neurochem. 100 (2007) 678-692
124. McCullough L.D., Blizzard K., Simpson E.R., Oz O.K., and Hurn P.D. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J. Neurosci. 23 (2003) 8701-8705
125. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D.G., and Guennoun R. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 (2007) 2505-2517
126. Mega M.S., Lee L., Dinov I.D., Mishkin F., Toga A.W., and Cummings J.L. Cerebral correlates of psychotic symptoms in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 69 (2000) 167-171
127. Melcangi R.C., and Garcia-Segura L.M. Therapeutic approaches to peripheral neuropathy based on neuroactive steroids. Expert Rev. Neurotherapeutics 6 (2006) 1121-1125
128. Melcangi R.C., Garcia-Segura L.M., and Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell Mol. Life Sci. 65 (2008) 777-797
129. Moldovan I.R., Cotleur A.C., Zamor N., Butler R.S., and Pelfrey C.M. Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens. J. Neuroimmunol. 193 (2008) 161-169
130. Morale M.C., L'Episcopo F., Tirolo C., Giaquinta G., Caniglia S., Testa N., Arcieri P., Serra P.A., Lupo G., Alberghina M., Harada N., Honda S., Panzica G.C., and Marchetti B. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?. Brain Res. Rev. 57 (2008) 431-443
131. Moran E.K., Becker J.A., Satlin A., Lyoo I.K., Fischman A.J., and Johnson K.A. Psychosis of Alzheimer's disease: gender differences in regional perfusion. Neurobiol. Aging 29 (2008) 1218-1225
132. Moreira P.I., Santos M.S., Oliveira C.R., Shenk J.C., Nunomura A., Smith M.A., Zhu X., and Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol. Disord. Drug Targets 7 (2008) 3-10
133. Moriarty P.J., Lieber D., Bennett A., White L., Parrella M., Harvey P.D., and Davis K.L. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr. Bull. 27 (2001) 103-113
134. Murmu M.S., Salomon S., Biala Y., Weinstock M., Braun K., and Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur. J. Neurosci. 24 (2006) 1477-1487
135. Nagarajan R.P., Hogart A.R., Gwye Y., Martin M.R., and LaSalle J.M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1 (2006) e1-e11
136. Ng I., Lee K.K., Lim J.H., Wong H.B., and Yan X.Y. Investigating gender differences in outcome following severe traumatic brain injury in a predominantly Asian population. Br. J. Neurosurg. 20 (2006) 73-78
137. Niemeier J.P., Marwitz J.H., Lesher K., Walker W.C., and Bushnik T. Gender differences in executive functions following traumatic brain injury. Neuropsychol. Rehabil. 17 (2007) 293-313
138. Niewada M., Kobayashi A., Sandercock P.A., Kaminski B., and Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 24 (2005) 123-128
139. Nishio H., Kasuga S., Ushijima M., and Harada Y. Prenatal stress and postnatal development of neonatal rats-sex-dependent effects on emotional behavior and learning ability of neonatal rats. Int. J. Dev. Neurosci. 19 (2001) 37-45
140. Noonan C.W., Kathman S.J., and White M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 58 (2002) 136-138
141. Orr A.L., Huang S., Roberts M.A., Reed J.C., Li S., and Li X.J. Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice. J. Biol. Chem. 283 (2008) 16027-16036
142. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., and Ebers G.C. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5 (2006) 932-936
143. Padua L., Aprile I., Cavallaro T., Commodari I., La Torre G., Pareyson D., Quattrone A., Rizzuto N., Vita G., Tonali P., and Schenone A. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurol. Sci. 27 (2006) 417-423
144. Palmen S.J., van Engeland H., Hof P.R., and Schmitz C. Neuropathological findings in autism. Brain 127 (2004) 2572-2583
145. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., and Pantelis C. Pituitary volume in psychosis. Br. J. Psychiatry 185 (2004) 5-10
146. Parmenter B.A., Denney D.R., Lynch S.G., Middleton L.S., and Harlan L.M. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Mult. Scler. 13 (2007) 25-32
147. Patchev V.K., Hayashi S., Orikasa C., and Almeida O.F. Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment. Stress 3 (1999) 41-54
148. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
149. Paulsen J.S., Salmon D.P., Thal L.J., Romero R., Weisstein-Jenkins C., Galasko D., Hofstetter C.R., Thomas R., Grant I., and Jeste D.V. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 54 (2000) 1965-1971
150. Pekmezovic T., Svetel M., Maric J., Dujmovic-Basuroski I., Dragasevic N., Keckarevic M., Romac S., and Kostic V.S. Survival of Huntington's disease patients in Serbia: longer survival in female patients. Eur. J. Epidemiol. 22 (2007) 523-526
151. Pelfrey C.M., Cotleur A.C., Lee J.C., and Rudick R.A. Sex differences in cytokine responses to myelin peptides in multiple sclerosis. J. Neuroimmunol. 130 (2002) 211-223
152. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C., and Bastianello S. Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 10 (2003) 95-97
153. Rao M.L., and Kolsch H. Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 28 Suppl. 2 (2003) 83-96
154. Ratcliff J.J., Greenspan A.I., Goldstein F.C., Stringer A.Y., Bushnik T., Hammond F.M., Novack T.A., Whyte J., and Wright D.W. Gender and traumatic brain injury: do the sexes fare differently?. Brain Inj. 21 (2007) 1023-1030
155. Razmara A., Krause D.N., and Duckles S.P. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am. J. Physiol, Heart Circ. Physiol. 289 (2005) H1843-1850
156. Reddy J., Waldner H., Zhang X., Illes Z., Wucherpfennig K.W., Sobel R.A., and Kuchroo V.K. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 5591-5595
157. Reeves M.J., Bushnell C.D., Howard G., Gargano J.W., Duncan P.W., Lynch G., Khatiwoda A., and Lisabeth L. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 7 (2008) 915-926
158. Reisert I., and Pilgrim C. Sexual differentiation of monoaminergic neurons-genetic or epigenetic?. Trends Neurosci. 14 (1991) 468-473
159. Reite M., Sheeder J., Teale P., Adams M., Richardson D., Simon J., Jones R.H., and Rojas D.C. Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. Arch. Gen. Psychiatry 54 (1997) 433-440
160. Riecher-Rossler A., and Hafner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr. Scand., Suppl. (2000) 58-62
161. Roberts R.E., and McLean W.G. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res. 754 (1997) 147-156
162. Rodriguez-Navarro J.A., Solano R.M., Casarejos M.J., Gomez A., Perucho J., de Yebenes J.G., and Mena M.A. Gender differences and estrogen effects in parkin null mice. J. Neurochem. 106 (2008) 2143-2157
163. Rogers S.J., Hepburn S., and Wehner E. Parent reports of sensory symptoms in toddlers with autism and those with other developmental disorders. J. Autism Dev. Disord. 33 (2003) 631-642
164. Roglio I., Giatti S., Pesaresi M., Bianchi R., Cavaletti G., Lauria G., Garcia-Segura L.M., and Melcangi R.C. Neuroactive steroids and peripheral neuropathy. Brain Res Rev. 57 (2008) 460-469
165. Roos R.A., Vegter-van der Vlis M., Hermans J., Elshove H.M., Moll A.C., van de Kamp J.J., and Bruyn G.W. Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. J. Med. Genet. 28 (1991) 515-519
166. Roquer J., Campello A.R., and Gomis M. Sex differences in first-ever acute stroke. Stroke 34 (2003) 1581-1585
167. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., and Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
168. Samaco R.C., Nagarajan R.P., Braunschweig D., and LaSalle J.M. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet. 13 (2004) 629-639
169. Savettieri G., Messina D., Andreoli V., Bonavita S., Caltagirone C., Cittadella R., Farina D., Fazio M.C., Girlanda P., Le Pira F., Liguori M., Lugaresi A., Nocentini U., Reggio A., Salemi G., Tedeschi G., Trojano M., Valentino P., and Quattrone A. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J. Neurol. 251 (2004) 1208-1214
170. Schafer S., Wirths O., Multhaup G., and Bayer T.A. Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J. Neural Transm. 114 (2007) 387-394
171. Schmitz C., Rhodes M.E., Bludau M., Kaplan S., Ong P., Ueffing I., Vehoff J., Korr H., and Frye C.A. Depression: reduced number of granule cells in the hippocampus of female, but not male, rats due to prenatal restraint stress. Mol. Psychiatry 7 (2002) 810-813
172. Schneider L.S., Katz I.R., Park S., Napolitano J., Martinez R.A., and Azen S.P. Psychosis of Alzheimer disease: validity of the construct and response to risperidone. Am. J. Geriatr. Psychiatry 11 (2003) 414-425
173. Schneider T., Roman A., Basta-Kaim A., Kubera M., Budziszewska B., Schneider K., and Przewlocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33 (2008) 728-740
174. Schwendimann R.N., and Alekseeva N. Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 377-392
175. Seidman L.J., Goldstein J.M., Goodman J.M., Koren D., Turner W.M., Faraone S.V., and Tsuang M.T. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability. Biol. Psychiatry 42 (1997) 104-115
176. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
177. Shors T.J., Chua C., and Falduto J. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J. Neurosci. 21 (2001) 6292-6297
178. Simonds V.M., and Whiffen V.E. Are gender differences in depression explained by gender differences in co-morbid anxiety?. J. Affect. Disord. 77 (2003) 197-202
179. Sinha S., Kaler L.J., Proctor T.M., Teuscher C., Vandenbark A.A., and Offner H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J. Immunol. 180 (2008) 2679-2685
180. Slewa-Younan S., Green A.M., Baguley I.J., Gurka J.A., and Marosszeky J.E. Sex differences in injury severity and outcome measures after traumatic brain injury. Arch. Phys. Med. Rehabil. 85 (2004) 376-379
181. Smith M., Hopkins D., Peveler R.C., Holt R.I., Woodward M., and Ismail K. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br. J. Psychiatry 192 (2008) 406-411
182. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., Yetkin O., Yanik M., Tutkun H., Savas H.A., Tarakcioglu M., and Akyol O. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta 331 (2003) 111-117
183. Stack C.M., Lim M.A., Cuasay K., Stone M.M., Seibert K.M., Spivak-Pohis I., Crawley J.N., Waschek J.A., and Hill J.M. Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp. Neurol. 211 (2008) 67-84
184. Sudlow C.L., and Warlow C.P. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28 (1997) 491-499
185. Swamydas M., Bessert D., and Skoff R. Sexual dimorphism of oligodendrocytes is mediated by differential regulation of signaling pathways. J. Neurosci. Res. 87 (2008) 3306-3319
186. Szuran T.F., Pliska V., Pokorny J., and Welzl H. Prenatal stress in rats: effects on plasma corticosterone, hippocampal glucocorticoid receptors, and maze performance. Physiol. Behav. 71 (2000) 353-362
187. Szymanski S., Lieberman J.A., Alvir J.M., Mayerhoff D., Loebel A., Geisler S., Chakos M., Koreen A., Jody D., Kane J., et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am. J. Psychiatry 152 (1995) 698-703
188. Takahashi T., Suzuki M., Kawasaki Y., Hagino H., Yamashita I., Nohara S., Nakamura K., Seto H., and Kurachi M. Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 53 (2003) 593-600
189. Towbin K.E., Pradella A., Gorrindo T., Pine D.S., and Leibenluft E. Autism spectrum traits in children with mood and anxiety disorders. J. Child Adolesc. Psychopharmacol. 15 (2005) 452-464
190. Turtzo L.C., and McCullough L.D. Sex differences in stroke. Cerebrovasc Dis. 26 (2008) 462-474
191. Vagnerova K., Koerner I.P., and Hurn P.D. Gender and the injured brain. Anesth. Analg. 107 (2008) 201-214
192. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., and Nelson L.M. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 157 (2003) 1015-1022
193. Vedel Kessing L. Gender differences in patients presenting with a single depressive episode according to ICD-10. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005) 197-201
194. Vina J., Lloret A., Valles S.L., Borras C., Badia M.C., Pallardo F.V., Sastre J., and Alonso M.D. Effect of gender on mitochondrial toxicity of Alzheimer's Abeta peptide. Antioxid. Redox Signal. 9 (2007) 1677-1690
195. Volkmar F.R., Szatmari P., and Sparrow S.S. Sex differences in pervasive developmental disorders. J. Autism Dev. Disord. 23 (1993) 579-591
196. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
197. Wagner A.K., Bayir H., Ren D., Puccio A., Zafonte R.D., and Kochanek P.M. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J. Neurotrauma 21 (2004) 125-136
198. Wagner A.K., Fabio A., Puccio A.M., Hirschberg R., Li W., Zafonte R.D., and Marion D.W. Gender associations with cerebrospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Crit. Care Med. 33 (2005) 407-413
199. Weinstock M. Gender differences in the effects of prenatal stress on brain development and behaviour. Neurochem. Res. 32 (2007) 1730-1740
200. Westberry J.M., Prewitt A.K., and Wilson M.E. Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 152 (2008) 982-989
201. Wooten G.F., Currie L.J., Bovbjerg V.E., Lee J.K., and Patrie J. Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 75 (2004) 637-639
202. Yu L., and Liao P.C. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107 (2000) 419-427
203. Zappia M., Annesi G., Nicoletti G., Arabia G., Annesi F., Messina D., Pugliese P., Spadafora P., Tarantino P., Carrideo S., Civitelli D., De Marco E.V., Ciro-Candiano I.C., Gambardella A., and Quattrone A. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch. Neurol. 62 (2005) 601-605
204. Zhang L., Li B., Zhao W., Chang Y.H., Ma W., Dragan M., Barker J.L., Hu Q., and Rubinow D.R. Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death. Brain Res. Mol. Brain Res. 103 (2002) 1-11
205. Zhang X.M., Zhu S.W., Duan R.S., Mohammed A.H., Winblad B., and Zhu J. Gender differences in susceptibility to kainic acid-induced neurodegeneration in aged C57BL/6 mice. Neurotoxicology 29 (2008) 406-412
206. Zoroglu S.S., Yurekli M., Meram I., Sogut S., Tutkun H., Yetkin O., Sivasli E., Savas H.A., Yanik M., Herken H., and Akyol O. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem. Funct. 21 (2003) 55-60